CLINICAL TRIALS INFORMATION
Medical advancements must undergo rigorous testing in the form of clinical trials before they can be made available for general use. Phase I and II studies assess safety. Phase III studies determine if new drugs are effective. Clinical trials represent the final stage of cutting edge science and medicine's pursuit of improved treatments.
The Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, conducts Phase II studies of treatment for neurological diseases. The network is sponsored by the National Institute of Neurological Disorders and Stroke (NINDS) and is comprised of 25 national clinical sites. Visit our website at www.neuronext.org.
NeuroNEXT Current Trials
UCLA NeuroNEXT contact: Catherine Canamar, Ph.D.
Neurology Department Clinical Trials
Clinical research activities are ongoing in many subspecialty areas including Alzheimer's disease, epilepsy, multiple sclerosis, amyotrophic lateral sclerosis, neurorehabilitation (stroke and spinal cord injury), and post-polio. For additional clinical trial information, contact the individual program.
Research Contacts and Web Listings of Current Trials by Program
Other Resources about Clinical Trials